Clinical and Paraclinical Characteristics of the Systemic Scleroderma Cohort According to the Criteria ACR 2013 and the History of Professional Exposure or of Agricultural Environment

Overview

The aim of the study is to compare the exposure to environmental and professional toxics by patients with systemic scleroderma and by patients not achieved by this pathology.

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Other
  • Study Primary Completion Date: December 31, 2020

Detailed Description

This study is based on a questionnaire. The data will be collected according a retrospective and prospective design : – at diagnostic of the disease – at the inclusion in the systemic scleroderma cohort – during the annual visit (in 2017-2018-2019-2020)

Clinical Trial Outcome Measures

Primary Measures

  • Questionnaire to evaluate the exposition of environmental and professional toxics
    • Time Frame: once a year up to 2020
    • clinical, personal and professional data

Participating in This Clinical Trial

Inclusion Criteria

  • Patients with systemic scleroderma Exclusion Criteria:

-

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Rennes University Hospital
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Patrick JEGO, Pr, Principal Investigator, Rennes University Hospital
  • Overall Contact(s)
    • Patrick JEGO, Pr, PATRICK.JEGO@CHU-RENNES.FR

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.